<p>
 Evaluating an immunization history, based on the recommendations of the ACIP schedule or other schedule is an important function provided by many IIS. Based on this evaluation and other factors, recommendations may be made for next doses due. Some of their trading partners would like to receive the outcome of this evaluation. The previous implementation guide included a method for accomplishing this using OBX segments but showed it in a VXU. This document illustrates how this is done in response to a request and expands on the types of information that may be messaged.
</p>
<p>
 A requesting system sends a query requesting and evaluated history and forecast for a specific person. (QBP^Q11^QBP_Q11, profile id=Z44) If that person is found in the responding system, the responding system evaluates the immunizations administered against a schedule (e.g. ACIP) and forecasts when next doses are due. These are returned in an RSP message. (RSP^K11^RSP_K11, profile id=Z42) If an exact match can’t be found an acknowledgement message is returned indicating no match or errors in the message.
</p>
<p>
 <br/>
</p>
<table style="width: 100%;">
 <tbody>
  <tr>
   <td style="width: 100.0000%;">
    <p>
     This document does not describe nor specify the functionality or accuracy of the forecasting service. The focus is only on the content of the messages. Implementations should publish documentation on local specifics.
    </p>
    <p>
     This document is not meant to support a call to a forecasting and evaluation service. It is meant to support existing applications that message vaccine forecasts and evaluation as a part of a complete immunization history.
    </p>
   </td>
  </tr>
 </tbody>
</table>
<p>
 <br/>
</p>
<p>
 When a clinician evaluates a person’s immunization history and makes recommendations, she/he must use a standard (schedule). Traditionally, clinicians have evaluated based on vaccine groups or families. The schedule has one or more sets of immunization events that can be satisfied to indicate protection against the diseases of the vaccine group of interest. These constitute a series.
</p>
<p>
 The following table lays out the information needed to convey an evaluation and forecast.
</p>
<p>
 <br/>
</p>
<table style="width: 100%;">
 <tbody>
  <tr>
   <td class="fr-thick" colspan="4" style="width: 99.8837%; text-align: center;">
    <strong>
     TABLE A-5 CODES SUPPORTING MESSAGING EVALUATION AND FORECASTING
    </strong>
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25%; text-align: center;">
    <strong>
     Data Element
    </strong>
   </td>
   <td class="fr-thick" style="width: 25.2325%; text-align: center;">
    <strong>
     Use
    </strong>
   </td>
   <td class="fr-thick" style="width: 24.7675%; text-align: center;">
    <strong>
     OBX-3 Value
    </strong>
   </td>
   <td class="fr-thick" style="width: 25%; text-align: center;">
    <strong>
     Optionality for meaningful evaluation and forecast
     <sup>
      39
     </sup>
    </strong>
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Schedule
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    Identifies the standards used. ACIP is the prototypical example.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59779-9
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Required
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Vaccine group/family
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    Identifies which diseases are expected to be prevented by completion of series.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    Vaccine type 30956-7
    <p>
     Combination vaccine component 38890-0
     <sup>
      40
     </sup>
    </p>
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Required
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Series name
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    Name of the specific set of doses and recommendations that were used to evaluate this dose and make recommendations.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59780-7
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Optional
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Ordinal position in primary series
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    Indicates which dose in a series this given immunization fulfills.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    30973-2
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Required
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Dose Validity
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    Indicates if this dose was given appropriately for this series in this schedule.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59781-5
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Optional
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Number of doses in Primary Series
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    <p>
     Indicates how many appropriately given doses are required to meet the goals of this series.
    </p>
    <p>
     Note that in the case where there are doses that may be skipped, due to the age of the client/patient, the number shall reflect the adjusted number of doses.
    </p>
    <br/>
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59782-3
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Optional
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Series Status
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    This indicates the status of the client’s progress toward meeting the goals of the series selected. This could be complete, overdue, in progress, etc.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59783-1
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Optional
   </td>
  </tr>
  <tr>
   <td class="fr-thick" rowspan="4" style="width: 25.0000%;">
    Next dose forecast
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    Earliest date dose should be given.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    30981-5
   </td>
   <td class="fr-thick" rowspan="4" style="width: 24.8837%;">
    Required for forecast
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.2325%;">
    Date next dose recommended
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    30980-7
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.2325%;">
    Latest date next dose should be given
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59777-3
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.2325%;">
    Date dose is overdue
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    59778-1
   </td>
  </tr>
  <tr>
   <td class="fr-thick" style="width: 25.0000%;">
    Reason code
   </td>
   <td class="fr-thick" style="width: 25.2325%;">
    This can indicate why a dose is not valid or that the recommendation was changed because of a special circumstance.
   </td>
   <td class="fr-thick" style="width: 24.7675%;">
    30982-3
   </td>
   <td class="fr-thick" style="width: 25.0000%;">
    Optional
   </td>
  </tr>
 </tbody>
</table>
<p>
 <br/>
</p>
<p>
 It is important to note that evaluation relates to doses received, but recommendations relate to doses not yet given. Each will be addressed separately. Evaluation will be associated with an immunization received. Recommendations will be associated with future events. That is, they will be associated with an RXA that indicates that no dose was given. They will not be associated with existing immunization records (RXA). This means that if a person has received one hep B dose (valid). The evaluation will be associated with the first RXA indicating that she/he received the dose. The OBX following this will indicate the evaluation. The recommendations for the next dose due will be associated with a second RXA.
</p>
<p>
 There are other factors relating to forecasting, such as exemption and previous immunity. These are dealt with in the client specific conditions impacting forecasting.
</p>
<p>
 When a given dose is evaluated against a schedule, we can make a number of observations about it. Each dose of vaccine recorded is transmitted in an RXA segment. Each RXA segment may have one or more OBX, observation segments. Each distinct piece of information is found in its own OBX segment and follows its associated RXA.
</p>
<p>
 <br/>
</p>
<table style="width: 100%;">
 <tbody>
  <tr>
   <td class="fr-thick" style="width: 100.0000%;">
    Note that the order of the OBX segments is not regulated. The receiving system will need to link the OBX with the appropriate data elements.
   </td>
  </tr>
 </tbody>
</table>
<p>
 <br/>
</p>
<p>
 The basic structure for including evaluation in a message is:
</p>
<p style="margin-left: 20px;">
 ORC-Order segment
</p>
<p style="margin-left: 20px;">
 RXA-the immunization and vaccine
</p>
<p style="margin-left: 20px;">
 OBX-vaccine group
</p>
<p style="margin-left: 20px;">
 OBX-the schedule
</p>
<p style="margin-left: 20px;">
 OBX-series used
</p>
<p style="margin-left: 20px;">
 OBX-dose number in series (ordinal position)
</p>
<p style="margin-left: 20px;">
 OBX-doses in series
</p>
<p style="margin-left: 20px;">
 OBX-dose validity
</p>
<p style="margin-left: 20px;">
 OBX-series status
</p>
<p>
 The basic structure for evaluation of combination vaccine components is:
</p>
<p style="margin-left: 20px;">
 ORC-order segment
</p>
<p style="margin-left: 20px;">
 RXA-the immunization and vaccine
</p>
<p style="margin-left: 20px;">
 OBX-vaccine group one
 <sup>
  41
 </sup>
</p>
<p style="margin-left: 20px;">
 OBX-the schedule
</p>
<p style="margin-left: 20px;">
 OBX-series used
</p>
<p style="margin-left: 20px;">
 OBX-dose number in series (ordinal position)
</p>
<p style="margin-left: 20px;">
 OBX-doses in series
</p>
<p style="margin-left: 20px;">
 OBX-dose validity
</p>
<p style="margin-left: 20px;">
 OBX-vaccine group two
 <sup>
  42
 </sup>
</p>
<p style="margin-left: 20px;">
 OBX-the schedule
</p>
<p style="margin-left: 20px;">
 OBX-series used
</p>
<p style="margin-left: 20px;">
 OBX-dose number in series (ordinal position)
</p>
<p style="margin-left: 20px;">
 OBX-doses in series
</p>
<p style="margin-left: 20px;">
 OBX-dose validity
</p>
<p style="margin-left: 20px;">
 OBX-series status
</p>
<p>
 The basic structure for the recommendation in the message is:
</p>
<p style="margin-left: 20px;">
 ORC-order segment
</p>
<p style="margin-left: 20px;">
 RXA-vaccine,
 <span style="color: rgb(184, 49, 47);">
  CVX-No Vaccine Administered (998)
 </span>
 OBX-the schedule
</p>
<p style="margin-left: 20px;">
 OBX-the series used
</p>
<p style="margin-left: 20px;">
 OBX-dose number in the series
</p>
<p style="margin-left: 20px;">
 OBX-number of doses in the series
</p>
<p style="margin-left: 20px;">
 OBX-earliest next dose due
</p>
<p style="margin-left: 20px;">
 OBX-recommended next dose due
</p>
<p style="margin-left: 20px;">
 OBX-overdue next dose due
</p>
<p style="margin-left: 20px;">
 OBX-series status
</p>
<p>
 This document will first illustrate how to build each OBX to support reporting the key information. The next section will show how to put these pieces together to create evaluation and recommendations in RSP message. Note that the same approach may be used in a VXU.
</p>
